Syed Yousuf Zafar | Scholars@Duke

Syed Yousuf Zafar
Associate Professor of Medicine

Dr. Zafar is a gastrointestinal medical oncologist and Associate Professor of Medicine, Public Policy, and Population Health Science at the Duke Cancer Institute and Duke-Margolis Center for Health Policy. He serves as Director of Healthcare Innovation at the Duke Cancer Institute. Dr. Zafar also serves as Clinical Associate Director of Duke Forge (Health Data Science Center). Dr. Zafar is considered an international expert in identifying and intervening upon the financial burden of cancer care. His research explores ways to improve cancer care delivery with a primary focus on improving the value of cancer treatment from both patient-focused and policy perspectives.

Dr. Zafar speaks internationally on his research and cancer care delivery. He has over 100 publications in top peer-reviewed journals including the New England Journal of Medicine, the Journal of Clinical Oncology, and JAMA Oncology. His research has been funded by the National Institutes of Health and the American Cancer Society, among others. His work has been covered by national media outlets including New York Times, Forbes, Wall Street Journal, NPR, and Washington Post. He is a Fellow of the American Society of Clinical Oncology.

Current Appointments & Affiliations

Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2019
Associate Professor in the Sanford School of Public Policy, Sanford School of Public Policy, Duke University 2016
Associate Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2019
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2005
Affiliate, Duke Global Health Institute, Duke Global Health Institute, University Institutes and Centers 2011
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2012
Core Faculty Member, Duke-Margolis Center for Health Policy, Duke - Margolis Center For Health Policy, Initiatives 2019
Associate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2020

Contact Information

Duke Box 3505, Durham, NC 27710
Seeley G. Mudd Building, Rm 43, 10 Bryan Searle Dr., DUMC 3505, Durham, NC 27710
yousuf.zafar@duke.edu (919) 684-8111
twitter

Background
Education, Training, & Certifications
- Fellow in Hematology-Oncology, Medicine, Duke University 2005 - 2008
- Resident, Medicine, University of Cincinnati 2002 - 2005
- M.D., The University of Toledo 2002
Duke Appointment History
- Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2014 - 2019
- Associate Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2018 - 2019
- Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2010 - 2014
- Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2008 - 2010
- Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2008
Leadership & Clinical Positions at Duke
- Director of Healthcare Innovation, Duke Cancer Institute
  Director, Center for Applied Cancer Health Policy
  Co-Leader, Health Care Delivery Focus Area, Cancer Control and Population Sciences
Recognition
In the News
- JUN 6, 2019 WBUR
  
  High Deductibles Push Millions Of Americans To Make 'Difficult Sacrifices' For Health Care
- JUN 6, 2019 LA Times
  
  Soaring insurance deductibles and high drug prices hit sick Americans with a ‘double whammy’
- FEB 21, 2019 New York Times
  
  The Financial Toxicity of Illness
- AUG 11, 2017 Duke Health News
  
  Out-of-Pocket Costs Exceed What Many Insured Cancer Patients Expect to Pay
- AUG 10, 2017 US News & World Report
  
  Cancer Takes Financial Toll, Even With Insurance
- AUG 10, 2017 Forbes
  
  Even Insured Patients Are Overwhelmed By The Cost Of Cancer Care
- AUG 10, 2017 NPR
  
  Widowed Early, A Cancer Doctor Writes About The Harm Of Medical Debt
- MAY 19, 2017 Duke Research Blog
  
  If the Cancer Doesn't Kill You, the Drug Bill Might
- JUN 6, 2016
  
  Cancer Patients with ACA Policies Swiftly Reach Out-of-Pocket Caps
- JUL 2, 2015 The Daily Mail
  
  How being obese could help you fight cancer
- JUL 1, 2015
  
  Thin Colorectal Cancer Patients Have Shorter Survival Than Obese Patients
- DEC 18, 2014
  
  ‘Financial Toxicity’ Can Lower Cancer Patients' Quality of Life
- JUN 14, 2013 New York Times
  
  Life, interrupted: The cost of cancer
Awards & Honors
Expertise
Subject Headings
Global Scholarship
- Research
  - United Republic of Tanzania (Country)
Research
Selected Grants
- Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care awarded by National Institutes of Health 2020 - 2025
- Couple Communication Skills Training for Advanced Cancer awarded by National Institutes of Health 2020 - 2024
- Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities awarded by National Institutes of Health 2019 - 2024
- Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training awarded by Dana Farber Cancer Institute 2018 - 2023
- Examining Best Practices for Factoring Out-Of-Pocket Expenses into Patients' Health Care Decisions 2018 - 2021
- Couple Communication in Cancer: A Multi-method Examination awarded by Arizona State University 2016 - 2021
- PAPNavigator STTR (Fast-Track) 2016 - 2019
- Using AACT - to answer Oncology landscape portfolio of open trials 2017 - 2018
- Financial Assistance, Navigation, and Communication Education (FinANCE): Development and pilot testing of a web-based financial toxicity intervention awarded by Brigham and Women's Hospital 2013 - 2015
- Does Comparative Effectiveness Research Promote Rationing or Rational Cancer Care? awarded by Greenwall Foundation 2013 - 2014
- CTSA KL2 awarded by National Institutes of Health 2006 - 2013
- Duke CTSA-KL2 awarded by National Institutes of Health 2006 - 2012
External Relationships
- AstraZeneca
- Cancer Support Community
- Change Healthcare
- Copernicus Group IRB
- Family Reach Foundation
- McKesson Corporation
- Quintiles
- RTI International
- Shattuck Labs
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Slavin, S. D., Khera, R., Zafar, S. Y., Nasir, K., & Warraich, H. J. (2021). Financial burden, distress, and toxicity in cardiovascular disease. Am Heart J, 238, 75–84. https://doi.org/10.1016/j.ahj.2021.04.011
    Full Text Link to Item
  - Oshima, S. M., Tait, S. D., Rushing, C., Lane, W., Hyslop, T., Offodile, A. C., … Fish, L. J. (2021). Patient Perspectives on the Financial Costs and Burdens of Breast Cancer Surgery. Jco Oncol Pract, 17(6), e872–e881. https://doi.org/10.1200/OP.20.00780
    Full Text Link to Item
  - Strickler, J. H., Rushing, C. N., Uronis, H. E., Morse, M. A., Niedzwiecki, D., Blobe, G. C., … Hurwitz, H. I. (2021). Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer. Oncologist, 26(6), 465-e917. https://doi.org/10.1002/onco.13678
    Full Text Link to Item
  - Tarnasky, A. M., Tran, G. N., Nicolla, J., Friedman, F. A. P., Wolf, S., Troy, J. D., … Zafar, S. Y. (2021). Mobile Application to Identify Cancer Treatment-Related Financial Assistance: Results of a Randomized Controlled Trial. Jco Oncol Pract, OP2000757. https://doi.org/10.1200/OP.20.00757
    Full Text Link to Item
  - Kelly, R. J., Ajani, J. A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., … CheckMate 577 Investigators, . (2021). Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. N Engl J Med, 384(13), 1191–1203. https://doi.org/10.1056/NEJMoa2032125
    Full Text Link to Item
  - Hussaini, S. M. Q., Chino, F., Rushing, C., Samsa, G., Altomare, I., Nicolla, J., … Zafar, S. Y. (2021). Does Cancer Treatment-Related Financial Distress Worsen Over Time? N C Med J, 82(1), 14–20. https://doi.org/10.18043/ncm.82.1.14
    Full Text Link to Item
  - Lou, E., Beg, M. S., Bergsland, E., Eng, C., Khorana, A. A., Kopetz, S., … Zafar, S. Y. (2020). Reply to S. Boutayeb et al. Jco Oncol Pract, 16(8), 525. https://doi.org/10.1200/OP.20.00394
    Full Text Link to Item
  - Lou, E., Beg, M. S., Bergsland, E., Eng, C., Khorana, A. A., Kopetz, S., … Zafar, S. Y. (2020). BRAF-Mutated Metastatic Colon Cancers During COVID-19 Pandemic Reply. Jco Oncology Practice, 16(8), 526-+.
    Link to Item
  - Moss, H. A., Wu, J., Kaplan, S. J., & Zafar, S. Y. (2020). The Affordable Care Act's Medicaid Expansion and Impact Along the Cancer-Care Continuum: A Systematic Review. J Natl Cancer Inst, 112(8), 779–791. https://doi.org/10.1093/jnci/djaa043
    Full Text Link to Item
  - Khera, N., Sugalski, J., Krause, D., Butterfield, R., Zhang, N., Stewart, F. M., … Lee, S. J. (2020). Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions. J Natl Compr Canc Netw, 18(7), 825–831. https://doi.org/10.6004/jnccn.2020.7538
    Full Text Link to Item
  - Lou, E., Beg, S., Bergsland, E., Eng, C., Khorana, A., Kopetz, S., … Zafar, S. Y. (2020). Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk. Jco Oncol Pract, 16(7), 383–388. https://doi.org/10.1200/OP.20.00239
    Full Text Link to Item
  - Zafar, S. Y., & Sanoff, H. K. (2020). Changing the Course of Cancer Care With Greater Precision. Jama Oncol, 6(5), 634–636. https://doi.org/10.1001/jamaoncol.2019.6843
    Full Text Link to Item
  - Tran, G., Harker, M., Chiswell, K., Unger, J. M., Fleury, M. E., Hirsch, B., … Zafar, S. Y. (2020). Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence. Jco Clin Cancer Inform, 4, 35–49. https://doi.org/10.1200/CCI.19.00088
    Full Text Link to Item
  - Strickler, J. H., Rushing, C. N., Niedzwiecki, D., McLeod, A., Altomare, I., Uronis, H. E., … Hurwitz, H. I. (2019). A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer. Bmc Cancer, 19(1), 1032. https://doi.org/10.1186/s12885-019-6234-8
    Full Text Link to Item
  - Clarke, J. M., Blobe, G. C., Strickler, J. H., Uronis, H. E., Zafar, S. Y., Morse, M., … Hurwitz, H. I. (2019). A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial). Cancer Chemother Pharmacol, 84(4), 909–917. https://doi.org/10.1007/s00280-019-03916-0
    Full Text Link to Item
  - Greenup, R. A., Rushing, C., Fish, L., Campbell, B. M., Tolnitch, L., Hyslop, T., … Hwang, E. S. (2019). Financial Costs and Burden Related to Decisions for Breast Cancer Surgery. J Oncol Pract, 15(8), e666–e676. https://doi.org/10.1200/JOP.18.00796
    Full Text Link to Item
  - Zullig, L. L., Ramos, K., Berkowitz, C., Miller, J. J., Dolor, R. J., Koontz, B. F., … Bosworth, H. B. (2019). Assessing Key Stakeholders' Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans. J Cancer Educ, 34(3), 584–591. https://doi.org/10.1007/s13187-018-1345-5
    Full Text Link to Item
  - Chino, F., & Zafar, S. Y. (2019). Financial Toxicity and Equitable Access to Clinical Trials. Am Soc Clin Oncol Educ Book, 39, 11–18. https://doi.org/10.1200/EDBK_100019
    Full Text Link to Item
  - Chino, F., Kamal, A. H., Leblanc, T. W., Zafar, S. Y., Suneja, G., & Chino, J. P. (2018). Place of death for patients with cancer in the United States, 1999 through 2015: Racial, age, and geographic disparities. Cancer, 124(22), 4408–4419. https://doi.org/10.1002/cncr.31737
    Full Text Link to Item
  - Zafar, S. Y., Polite, B. N., & McClellan, M. (2018). Engaging Patients in Value-Based Cancer Care: A Missed Opportunity. Jama Oncol, 4(11), 1479–1480. https://doi.org/10.1001/jamaoncol.2018.2826
    Full Text Link to Item
  - Sitlinger, A., & Zafar, S. Y. (2018). Health-Related Quality of Life: The Impact on Morbidity and Mortality. Surg Oncol Clin N Am, 27(4), 675–684. https://doi.org/10.1016/j.soc.2018.05.008
    Full Text Link to Item
  - Chino, F., Peppercorn, J. M., Rushing, C., Nicolla, J., Kamal, A. H., Altomare, I., … Zafar, S. Y. (2018). Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care. J Oncol Pract, 14(9), e533–e546. https://doi.org/10.1200/JOP.18.00112
    Full Text Link to Item
  - Hastert, T. A., Young, G. S., Pennell, M. L., Padamsee, T., Zafar, S. Y., DeGraffinreid, C., … Paskett, E. D. (2018). Financial burden among older, long-term cancer survivors: Results from the LILAC study. Cancer Med, 7(9), 4261–4272. https://doi.org/10.1002/cam4.1671
    Full Text Link to Item
  - Leopold, C., Peppercorn, J. M., Zafar, S. Y., & Wagner, A. K. (2018). Defining Value of Cancer Therapeutics-A Health System Perspective. J Natl Cancer Inst, 110(7), 699–703. https://doi.org/10.1093/jnci/djy079
    Full Text Link to Item
  - Vlahovic, G., Meadows, K. L., Hatch, A. J., Jia, J., Nixon, A. B., Uronis, H. E., … Hurwitz, H. I. (2018). A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist, 23(7), 782–790. https://doi.org/10.1634/theoncologist.2016-0377
    Full Text Link to Item
  - Chan, R. J., Gordon, L., Zafar, S. Y., & Miaskowski, C. (2018). Financial toxicity and symptom burden: what is the big deal? Support Care Cancer, 26(5), 1357–1359. https://doi.org/10.1007/s00520-018-4092-6
    Full Text Link to Item
  - Tran, G., & Zafar, S. Y. (2018). Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med, 6(9), 166. https://doi.org/10.21037/atm.2018.03.28
    Full Text Link to Item
  - Shih, Y.-C., Nasso, S. F., & Zafar, S. Y. (2018). Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care. Pharmacoeconomics, 36(3), 259–261. https://doi.org/10.1007/s40273-018-0613-x
    Full Text Link to Item
  - Moss, H. A., Havrilesky, L. J., Zafar, S. Y., Suneja, G., & Chino, J. (2018). Trends in Insurance Status Among Patients Diagnosed With Cancer Before and After Implementation of the Affordable Care Act. J Oncol Pract, 14(2), e92–e102. https://doi.org/10.1200/JOP.2017.027102
    Full Text Link to Item
  - Tran, G., & Zafar, S. Y. (2018). Price of Cancer Care and Its Tax on Quality of Life. J Oncol Pract, 14(2), 69–71. https://doi.org/10.1200/JOP.2017.028498
    Full Text Link to Item
  - Williams, G. R. (2018). Geriatric Assessment: Precision Medicine for Older Adults With Cancer. Journal of Oncology Practice, 14(2), 97–98. https://doi.org/10.1200/jop.18.00010
    Full Text
  - Langer, S. L., Romano, J. M., Todd, M., Strauman, T. J., Keefe, F. J., Syrjala, K. L., … Porter, L. S. (2018). Links Between Communication and Relationship Satisfaction Among Patients With Cancer and Their Spouses: Results of a Fourteen-Day Smartphone-Based Ecological Momentary Assessment Study. Front Psychol, 9, 1843. https://doi.org/10.3389/fpsyg.2018.01843
    Full Text Open Access Copy Link to Item
  - Sitlinger, A. P., & Zafar, S. Y. (2018). With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern. Dis Colon Rectum, 61(1), 4–5. https://doi.org/10.1097/DCR.0000000000000922
    Full Text Link to Item
  - Sloan, C., & Zafar, S. Y. (2018). Ask Early and Ask Often: How Discussing Costs Could Save Your Patient's Life. N C Med J, 79(1), 39–42. https://doi.org/10.18043/ncm.79.1.39
    Full Text Link to Item
  - Chino, F., Peppercorn, J. M., Rushing, C., Kamal, A. H., Altomare, I., Samsa, G., & Zafar, S. Y. (2017). Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care. Jama Oncol, 3(11), 1582–1584. https://doi.org/10.1001/jamaoncol.2017.2148
    Full Text Link to Item
  - Hunter, W. G., Zafar, S. Y., Hesson, A., Davis, J. K., Kirby, C., Barnett, J. A., & Ubel, P. A. (2017). Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters. J Oncol Pract, 13(11), e944–e956. https://doi.org/10.1200/JOP.2017.022855
    Full Text Link to Item
  - Porter, L. S., Keefe, F. J., Baucom, D. H., Olsen, M., Zafar, S. Y., & Uronis, H. (2017). A randomized pilot trial of a videoconference couples communication intervention for advanced GI cancer. Psychooncology, 26(7), 1027–1035. https://doi.org/10.1002/pon.4121
    Full Text Link to Item
  - Zafar, S. Y., & Peppercorn, J. M. (2017). Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care? J Clin Oncol, 35(19), 2113–2116. https://doi.org/10.1200/JCO.2016.71.7280
    Full Text Link to Item
  - Mowery, Y. M., Salama, J. K., Zafar, S. Y., Moore, H. G., Willett, C. G., Czito, B. G., … Palta, M. (2017). Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States. Cancer, 123(8), 1434–1441. https://doi.org/10.1002/cncr.30461
    Full Text Link to Item
  - Zullig, L. L., Wolf, S., Vlastelica, L., Shankaran, V., & Zafar, S. Y. (2017). The Role of Patient Financial Assistance Programs in Reducing Costs for Cancer Patients. J Manag Care Spec Pharm, 23(4), 407–411. https://doi.org/10.18553/jmcp.2017.23.4.407
    Full Text Link to Item
  - Zafar, S. Y., Peppercorn, J., Asabere, A., & Bastian, A. (2017). Transparency of Industry-Sponsored Oncology Patient Financial Assistance Programs Using a Patient-Centered Approach. J Oncol Pract, 13(3), e240–e248. https://doi.org/10.1200/JOP.2016.017509
    Full Text Link to Item
  - Zafar, S. Y., Newcomer, L. N., McCarthy, J., Fuld Nasso, S., & Saltz, L. B. (2017). How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives. Am Soc Clin Oncol Educ Book, 37, 35–39. https://doi.org/10.1200/EDBK_174893
    Full Text Link to Item
  - Zullig, L. L., Schroeder, K., Nyindo, P., Namwai, T., Silayo, E., Msomba, A., … Zafar, S. Y. (2016). Validation and Quality Assessment of the Kilimanjaro Cancer Registry. J Glob Oncol, 2(6), 381–386. https://doi.org/10.1200/JGO.2015.002873
    Full Text Open Access Copy Link to Item
  - Chino, F., Peppercorn, J. M., Rushing, C., Samsa, G., Nicolla, J., Altomare, I., & Zafar, S. Y. (2016). "Going for Broke": Out-of-Pocket Costs, Financial Distress, and Patient-Reported Willingness to Pay and Sacrifice in Cancer Care. Int J Radiat Oncol Biol Phys, 96(2S), S135–S136. https://doi.org/10.1016/j.ijrobp.2016.06.330
    Full Text Link to Item
  - Mowery, Y. M., Salama, J. K., Zafar, S. Y., Moore, H. G., Willett, C. G., Czito, B., … Palta, M. (2016). Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States. Int J Radiat Oncol Biol Phys, 96(2S), S203. https://doi.org/10.1016/j.ijrobp.2016.06.505
    Full Text Link to Item
  - Wollins, D. S., & Zafar, S. Y. (2016). A Touchy Subject: Can Physicians Improve Value by Discussing Costs and Clinical Benefits With Patients? Oncologist, 21(10), 1157–1160. https://doi.org/10.1634/theoncologist.2016-0207
    Full Text Link to Item
  - Hochman, M. J., Wolf, S., Zafar, S. Y., Portman, D., Bull, J., & Kamal, A. H. (2016). Comparing Unmet Needs to Optimize Quality: Characterizing Inpatient and Outpatient Palliative Care Populations. J Pain Symptom Manage, 51(6), 1033-1039.e3. https://doi.org/10.1016/j.jpainsymman.2015.12.338
    Full Text Link to Item
  - Nipp, R. D., Zullig, L. L., Samsa, G., Peppercorn, J. M., Schrag, D., Taylor, D. H., … Zafar, S. Y. (2016). Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress. Psychooncology, 25(6), 719–725. https://doi.org/10.1002/pon.3911
    Full Text Link to Item
  - Lathan, C. S., Cronin, A., Tucker-Seeley, R., Zafar, S. Y., Ayanian, J. Z., & Schrag, D. (2016). Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer. J Clin Oncol, 34(15), 1732–1740. https://doi.org/10.1200/JCO.2015.63.2232
    Full Text Link to Item
  - Zafar, S. Y. (2016). Financial Toxicity of Cancer Care: It's Time to Intervene. J Natl Cancer Inst, 108(5). https://doi.org/10.1093/jnci/djv370
    Full Text Link to Item
  - Altomare, I., Irwin, B., Zafar, S. Y., Houck, K., Maloney, B., Greenup, R., & Peppercorn, J. (2016). Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. J Oncol Pract, 12(3), e281-248. https://doi.org/10.1200/JOP.2015.007401
    Full Text Link to Item
  - Roe, M. T., Cyr, D. D., Eckart, D., Schulte, P. J., Morse, M. A., Blackwell, K. L., … TRILOGY ACS Investigators, . (2016). Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. Eur Heart J, 37(4), 412–422. https://doi.org/10.1093/eurheartj/ehv611
    Full Text Link to Item
  - Kircher, S. M., Meeker, C. R., Nimeiri, H., Geynisman, D. M., Zafar, S. Y., Shankaran, V., … Wong, Y.-N. (2016). The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications? Value Health, 19(1), 88–98. https://doi.org/10.1016/j.jval.2015.10.005
    Full Text Link to Item
  - Deming, D., Uboha, N., Zafar, S. Y., Rosenberg, S., Bassetti, M., Glasgow, S., … Lubner, S. (2015). Adjuvant Chemotherapy for Stage II Rectal Cancer. Semin Oncol, 42(6), e99-107. https://doi.org/10.1053/j.seminoncol.2015.09.033
    Full Text Link to Item
  - Zafar, S. Y., Chino, F., Ubel, P. A., Rushing, C., Samsa, G., Altomare, I., … Peppercorn, J. M. (2015). The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care, 21(9), 607–615.
    Link to Item
  - Nipp, R. D., Currow, D. C., Cherny, N. I., Strasser, F., Abernethy, A. P., & Zafar, S. Y. (2015). Best supportive care in clinical trials: review of the inconsistency in control arm design. Br J Cancer, 113(1), 6–11. https://doi.org/10.1038/bjc.2015.192
    Full Text Link to Item
  - Kutner, J. S., Blatchford, P. J., Taylor, D. H., Ritchie, C. S., Bull, J. H., Fairclough, D. L., … Abernethy, A. P. (2015). Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. Jama Intern Med, 175(5), 691–700. https://doi.org/10.1001/jamainternmed.2015.0289
    Full Text Link to Item
  - Zafar, S. Y., Ubel, P. A., Tulsky, J. A., & Pollak, K. I. (2015). Cost-related health literacy: a key component of high-quality cancer care. J Oncol Pract, 11(3), 171–173. https://doi.org/10.1200/JOP.2015.004408
    Full Text Link to Item
  - Zafar, S. Y., McNeil, R. B., Thomas, C. M., Lathan, C. S., Ayanian, J. Z., & Provenzale, D. (2015). Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract, 11(2), 145–150. https://doi.org/10.1200/JOP.2014.001542
    Full Text Link to Item
  - Corrigendum. (2015). Future Oncol, 11(3), 544. https://doi.org/10.2217/fon.14.304
    Full Text Link to Item
  - Kasi, P. M., Zafar, S. Y., & Grothey, A. (2015). Is obesity an advantage in patients with colorectal cancer? Expert Rev Gastroenterol Hepatol, 9(11), 1339–1342. https://doi.org/10.1586/17474124.2015.1089170
    Full Text Link to Item
  - Bestvina, C. M., Zullig, L. L., & Yousuf Zafar, S. (2014). The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature. Future Oncol, 10(14), 2189–2199. https://doi.org/10.2217/fon.14.130
    Full Text Link to Item
  - Taylor, D. H., Danis, M., Zafar, S. Y., Howie, L. J., Samsa, G. P., Wolf, S. P., & Abernethy, A. P. (2014). There is a mismatch between the medicare benefit package and the preferences of patients with cancer and their caregivers. J Clin Oncol, 32(28), 3163–3168. https://doi.org/10.1200/JCO.2013.54.2605
    Full Text Link to Item
  - Smith, S. K., Nicolla, J., & Zafar, S. Y. (2014). Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract, 10(5), e368–e372. https://doi.org/10.1200/JOP.2013.001342
    Full Text Link to Item
  - Rangwala, F., Bendell, J. C., Kozloff, M. F., Arrowood, C. C., Dellinger, A., Meadows, J., … Hurwitz, H. I. (2014). Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs, 32(4), 700–709. https://doi.org/10.1007/s10637-014-0089-2
    Full Text Link to Item
  - Danis, M., Abernethy, A. P., Zafar, S. Y., Samsa, G. P., Wolf, S. P., Howie, L., & Taylor, D. H. (2014). A decision exercise to engage cancer patients and families in deliberation about Medicare coverage for advanced cancer care. Bmc Health Serv Res, 14, 315. https://doi.org/10.1186/1472-6963-14-315
    Full Text Link to Item
  - Zafar, S. Y., Tulsky, J. A., & Abernethy, A. P. (2014). It's time to have 'the talk': cost communication and patient-centered care. Oncology (Williston Park), 28(6), 479–480.
    Link to Item
  - De Boer, C., Niyonzima, N., Orem, J., Bartlett, J., & Zafar, S. Y. (2014). Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: A cross-sectional study. Infectious Agents and Cancer, 9(1). https://doi.org/10.1186/1750-9378-9-17
    Full Text
  - Bestvina, C. M., Zullig, L. L., Rushing, C., Chino, F., Samsa, G. P., Altomare, I., … Zafar, S. Y. (2014). Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract, 10(3), 162–167. https://doi.org/10.1200/JOP.2014.001406
    Full Text Link to Item
  - Chino, F., Peppercorn, J., Taylor, D. H., Lu, Y., Samsa, G., Abernethy, A. P., & Zafar, S. Y. (2014). Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist, 19(4), 414–420. https://doi.org/10.1634/theoncologist.2013-0374
    Full Text Link to Item
  - Strickler, J. H., McCall, S., Nixon, A. B., Brady, J. C., Pang, H., Rushing, C., … Hurwitz, H. I. (2014). Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer. Invest New Drugs, 32(2), 330–339. https://doi.org/10.1007/s10637-013-0042-9
    Full Text Link to Item
  - van Ryn, M., Phelan, S. M., Arora, N. K., Haggstrom, D. A., Jackson, G. L., Zafar, S. Y., … Clauser, S. B. (2014). Patient-reported quality of supportive care among patients with colorectal cancer in the Veterans Affairs Health Care System. J Clin Oncol, 32(8), 809–815. https://doi.org/10.1200/JCO.2013.49.4302
    Full Text Link to Item
  - Peppercorn, J., Zafar, S. Y., Houck, K., Ubel, P., & Meropol, N. J. (2014). Does comparative effectiveness research promote rationing of cancer care? Lancet Oncol, 15(3), e132–e138. https://doi.org/10.1016/S1470-2045(13)70597-7
    Full Text Link to Item
  - Bartley, A. N., Hamilton, S. R., Alsabeh, R., Ambinder, E. P., Berman, M., Collins, E., … Members of the Cancer Biomarker Reporting Workgroup, College of American Pathologists, . (2014). Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum. Arch Pathol Lab Med, 138(2), 166–170. https://doi.org/10.5858/arpa.2013-0231-CP
    Full Text Link to Item
  - De Boer, C., Niyonzima, N., Orem, J., Bartlett, J., & Zafar, S. Y. (2014). Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: a cross-sectional study. Infect Agent Cancer, 9, 17. https://doi.org/10.1186/1750-9378-9-17
    Full Text Link to Item
  - Hirsch, B. R., & Zafar, S. Y. (2014). Comparative effectiveness research: moving medical oncology forward. Semin Radiat Oncol, 24(1), 49–53. https://doi.org/10.1016/j.semradonc.2013.08.005
    Full Text Link to Item
  - Peppercorn, J., Zafar, S. Y., Houck, K., Ubel, P., & Meropol, N. J. (2014). Does comparative effectiveness research promote rationing of cancer care? The Lancet Oncology, 15(3), e132–e138.
  - Yousuf Zafar, S., Tulsky, J. A., & Abernethy, A. P. (2014). It's time to have 'The talk': Cost communication and patient-centered care. Oncology (United States), 28(6), 13.
  - Zullig, L. L., Peppercorn, J. M., Schrag, D., Taylor, D. H., Lu, Y., Samsa, G., … Zafar, S. Y. (2013). Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer. J Oncol Pract, 9(6S), 60s-63s. https://doi.org/10.1200/JOP.2013.000971
    Full Text Link to Item
  - Ubel, P. A., Abernethy, A. P., & Zafar, S. Y. (2013). Full disclosure--out-of-pocket costs as side effects. N Engl J Med, 369(16), 1484–1486. https://doi.org/10.1056/NEJMp1306826
    Full Text Link to Item
  - Jackson, G. L., Zullig, L. L., Zafar, S. Y., Powell, A. A., Ordin, D. L., Gellad, Z. F., … Provenzale, D. (2013). Using NCCN clinical practice guidelines in oncology to measure the quality of colorectal cancer care in the veterans health administration. J Natl Compr Canc Netw, 11(4), 431–441. https://doi.org/10.6004/jnccn.2013.0058
    Full Text Link to Item
  - Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part II: how can we help with the burden of treatment-related costs? Oncology (Williston Park), 27(4), 253–256.
    Link to Item
  - Fouad, M. N., Lee, J. Y., Catalano, P. J., Vogt, T. M., Zafar, S. Y., West, D. W., … Kiefe, C. I. (2013). Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract, 9(2), e40–e47. https://doi.org/10.1200/JOP.2012.000598
    Full Text Link to Item
  - Zafar, S. Y., Malin, J. L., Grambow, S. C., Abbott, D. H., Kolimaga, J. T., Zullig, L. L., … Cancer Care Outcomes Research & Surveillance CanCORS Consortium, . (2013). Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. Cancer, 119(4), 854–862. https://doi.org/10.1002/cncr.27815
    Full Text Link to Item
  - Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park), 27(2), 80–149.
    Link to Item
  - Phelan, S. M., Griffin, J. M., Jackson, G. L., Zafar, S. Y., Hellerstedt, W., Stahre, M., … van Ryn, M. (2013). Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer. Psychooncology, 22(1), 65–73. https://doi.org/10.1002/pon.2048
    Full Text Link to Item
  - Uronis, H. E., Bendell, J. C., Altomare, I., Blobe, G. C., Hsu, S. D., Morse, M. A., … Hurwitz, H. I. (2013). A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas. Oncologist, 18(3), 271–272. https://doi.org/10.1634/theoncologist.2012-0404
    Full Text Link to Item
  - Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park, N.Y.), 27(2).
  - Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part II: how can we help with the burden of treatment-related costs? Oncology (Williston Park, N.Y.), 27(4).
  - Zafar, S. Y., Peppercorn, J. M., Schrag, D., Taylor, D. H., Goetzinger, A. M., Zhong, X., & Abernethy, A. P. (2013). The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist, 18(4), 381–390. https://doi.org/10.1634/theoncologist.2012-0279
    Full Text Link to Item
  - Zullig, L. L., Muiruri, C., Abernethy, A., Weiner, B. J., Bartlett, J., Oneko, O., & Zafar, S. Y. (2013). Cancer registration needs assessment at a tertiary medical centre in Kilimanjaro, Tanzania. World Health Popul, 14(2), 12–23. https://doi.org/10.12927/whp.2013.23271
    Full Text Link to Item
  - Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., … TRILOGY ACS Investigators, . (2012). Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med, 367(14), 1297–1309. https://doi.org/10.1056/NEJMoa1205512
    Full Text Link to Item
  - Strickler, J. H., Starodub, A. N., Jia, J., Meadows, K. L., Nixon, A. B., Dellinger, A., … Hurwitz, H. I. (2012). Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors. Cancer Chemother Pharmacol, 70(2), 251–258. https://doi.org/10.1007/s00280-012-1911-1
    Full Text Link to Item
  - Vlahovic, G., Meadows, K. L., Uronis, H. E., Morse, M. A., Blobe, G. C., Riedel, R. F., … Hurwitz, H. I. (2012). A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors. Cancer Chemother Pharmacol, 70(1), 95–102. https://doi.org/10.1007/s00280-012-1889-8
    Full Text Link to Item
  - Currow, D. C., Tieman, J. J., Greene, A., Zafar, S. Y., Wheeler, J. L., & Abernethy, A. P. (2012). Refining a checklist for reporting patient populations and service characteristics in hospice and palliative care research. J Pain Symptom Manage, 43(5), 902–910. https://doi.org/10.1016/j.jpainsymman.2011.05.015
    Full Text Link to Item
  - Palta, M., Patel, P., Broadwater, G., Willett, C., Pepek, J., Tyler, D., … Czito, B. (2012). Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol, 19(5), 1535–1540. https://doi.org/10.1245/s10434-011-2117-1
    Full Text Link to Item
  - Rangwala, F., Zafar, S. Y., & Abernethy, A. P. (2012). Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach. Curr Opin Support Palliat Care, 6(1), 69–76. https://doi.org/10.1097/SPC.0b013e32834f689d
    Full Text Link to Item
  - Zafar, S. Y., Currow, D. C., Cherny, N., Strasser, F., Fowler, R., & Abernethy, A. P. (2012). Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol, 13(2), e77–e82. https://doi.org/10.1016/S1470-2045(11)70215-7
    Full Text Link to Item
  - Zafar, S. Y., Malin, J. L., Grambow, S. C., Abbott, D. H., Schrag, D., Kolimaga, J. T., … Cancer Care and Outcomes Research and Surveillance (CanCORS) Consortium, . (2011). Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. Bmc Cancer, 11, 354. https://doi.org/10.1186/1471-2407-11-354
    Full Text Link to Item
  - Bullock, K. E., Petros, W. P., Younis, I., Uronis, H. E., Morse, M. A., Blobe, G. C., … Bendell, J. C. (2011). A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE). Cancer Chemother Pharmacol, 67(2), 465–474. https://doi.org/10.1007/s00280-010-1507-6
    Full Text Link to Item
  - Currow, D. C., Foley, K., Zafar, S. Y., Wheeler, J. L., & Abernethy, A. P. (2011). The need for a re-evaluation of best supportive care studies reported to date. Br J Cancer, 104(3), 390–391. https://doi.org/10.1038/sj.bjc.6606081
    Full Text Link to Item
  - Altomare, I., Bendell, J. C., Bullock, K. E., Uronis, H. E., Morse, M. A., Hsu, S. D., … Hurwitz, H. I. (2011). A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer. Oncologist, 16(8), 1131–1137. https://doi.org/10.1634/theoncologist.2011-0078
    Full Text Link to Item
  - Hirsch, B. R., & Zafar, S. Y. (2011). Capecitabine in the management of colorectal cancer. Cancer Manag Res, 3, 79–89. https://doi.org/10.2147/CMR.S11250
    Full Text Link to Item
  - Abernethy, A. P., Aziz, N. M., Basch, E., Bull, J., Cleeland, C. S., Currow, D. C., … Kutner, J. S. (2010). A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med, 13(12), 1407–1413. https://doi.org/10.1089/jpm.2010.0261
    Full Text Open Access Copy Link to Item
  - Abernethy, A. P., Zafar, S. Y., Uronis, H., Wheeler, J. L., Coan, A., Rowe, K., … Herndon, J. E. (2010). Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage, 40(4), 545–558. https://doi.org/10.1016/j.jpainsymman.2010.01.017
    Full Text Link to Item
  - Zafar, S. Y., Currow, D. C., Daugherty, C. K., & Abernethy, A. P. (2010). Standards for palliative care delivery in oncology settings. Cancer J, 16(5), 436–443. https://doi.org/10.1097/PPO.0b13e3181f289f7
    Full Text Link to Item
  - Bull, J., Zafar, S. Y., Wheeler, J. L., Harker, M., Gblokpor, A., Hanson, L., … Abernethy, A. P. (2010). Establishing a regional, multisite database for quality improvement and service planning in community-based palliative care and hospice. J Palliat Med, 13(8), 1013–1020. https://doi.org/10.1089/jpm.2010.0017
    Full Text Open Access Copy Link to Item
  - Jackson, G. L., Melton, L. D., Abbott, D. H., Zullig, L. L., Ordin, D. L., Grambow, S. C., … Provenzale, D. (2010). Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs. J Clin Oncol, 28(19), 3176–3181. https://doi.org/10.1200/JCO.2009.26.7948
    Full Text Link to Item
  - Abernethy, A. P., Ahmad, A., Zafar, S. Y., Wheeler, J. L., Reese, J. B., & Lyerly, H. K. (2010). Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care, 48(6 Suppl), S32–S38. https://doi.org/10.1097/MLR.0b013e3181db53a4
    Full Text Link to Item
  - Abernethy, A. P., Wheeler, J. L., & Zafar, S. Y. (2010). Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care, 4(1), 36–45. https://doi.org/10.1097/SPC.0b013e32833575fd
    Full Text Link to Item
  - Chrischilles, E. A., Pendergast, J. F., Kahn, K. L., Wallace, R. B., Moga, D. C., Harrington, D. P., … Fletcher, R. H. (2010). Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol, 28(4), 620–627. https://doi.org/10.1200/JCO.2009.23.8485
    Full Text Link to Item
  - Zafar, S. Y., Marcello, J. E., Wheeler, J. L., Rowe, K. L., Morse, M. A., Herndon, J. E., & Abernethy, A. P. (2010). Treatment-related toxicity and supportive care in metastatic colorectal cancer. J Support Oncol, 8(1), 15–20.
    Link to Item
  - Cherny, N. I., Abernethy, A. P., Strasser, F., Sapir, R., Currow, D., & Zafar, S. Y. (2009). Improving the methodologic and ethical validity of best supportive care studies in oncology: lessons from a systematic review. J Clin Oncol, 27(32), 5476–5486. https://doi.org/10.1200/JCO.2009.21.9592
    Full Text Link to Item
  - Zafar, S. Y., Marcello, J. E., Wheeler, J. L., Rowe, K. L., Morse, M. A., Herndon, J. E., & Abernethy, A. P. (2009). Longitudinal patterns of chemotherapy use in metastatic colorectal cancer. J Oncol Pract, 5(5), 228–233. https://doi.org/10.1200/JOP.091010
    Full Text Link to Item
  - Abernethy, A. P., Barbour, S. Y., Uronis, H., Zafar, S. Y., Coan, A., Rowe, K., … Herndon, J. E. (2009). Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center. Support Care Cancer, 17(6), 735–744. https://doi.org/10.1007/s00520-008-0562-6
    Full Text Link to Item
  - Abernethy, A. P., Zafar, S. Y., Coeytaux, R., Rowe, K., Wheeler, J. L., & Lyerly, H. K. (2009). Electronic patient-reported data capture as the foundation of a learning health care system. J Clin Oncol, 27(15_suppl), 6522.
    Link to Item
  - Bullock, K. E., Hurwitz, H. I., Uronis, H. E., Morse, M. A., Blobe, G. C., Hsu, S. D., … Bendell, J. C. (2009). Bevacizumab (B) plus everolimus (E) in refractory metastatic colorectal cancer (mCRC). J Clin Oncol, 27(15_suppl), 4080.
    Link to Item
  - Dupont, A., Wheeler, J., Herndon, J. E., Coan, A., Zafar, S. Y., Hood, L., … Abernethy, A. P. (2009). Use of tablet personal computers for sensitive patient-reported information. J Support Oncol, 7(3), 91–97.
    Link to Item
  - Abernethy, A. P., Wheeler, J. L., & Zafar, S. Y. (2009). Detailing of gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, new insights, and a proposed approach. Curr Opin Support Palliat Care, 3(1), 41–49. https://doi.org/10.1097/SPC.0b013e32832531ce
    Full Text Link to Item
  - Zafar, S. Y., Abernethy, A. P., & Currow, D. (2009). To the editor. Journal of Clinical Oncology, 27(5), 829. https://doi.org/10.1200/JCO.2008.20.6029
    Full Text
  - Zafar, S. Y., Alexander, S. C., Weinfurt, K. P., Schulman, K. A., & Abernethy, A. P. (2009). Decision making and quality of life in the treatment of cancer: a review. Support Care Cancer, 17(2), 117–127. https://doi.org/10.1007/s00520-008-0505-2
    Full Text Link to Item
  - Yousuf, S. Y., Abernethy, A. P., Abbott, D. H., Grambow, S. C., Marcello, J. E., Herndon, J. E., … Provenzale, D. T. (2008). Comorbidity, age, race and stage at diagnosis in colorectal cancer: A retrospective, parallel analysis of two health systems. Bmc Cancer, 8. https://doi.org/10.1186/1471-2407-8-345
    Full Text
  - Zafar, S. Y., Abernethy, A. P., Abbott, D. H., Grambow, S. C., Marcello, J. E., Herndon, J. E., … Provenzale, D. T. (2008). Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. Bmc Cancer, 8, 345. https://doi.org/10.1186/1471-2407-8-345
    Full Text Open Access Copy Link to Item
  - Zafar, S. Y., Currow, D., & Abernethy, A. P. (2008). Defining best supportive care. J Clin Oncol, 26(31), 5139–5140. https://doi.org/10.1200/JCO.2008.19.7491
    Full Text Link to Item
  - Zafar, S. Y., Howell, D. N., & Gockerman, J. P. (2008). Malignancy after solid organ transplantation: an overview. Oncologist, 13(7), 769–778. https://doi.org/10.1634/theoncologist.2007-0251
    Full Text Link to Item
  - Zafar, Y., & Hurwitz, H. I. (2007). Monoclonal antibodies to EGFR: What does the future hold? Oncology, 21(8), 976–977.
  - Zafar, Y., & Hurwitz, H. I. (2007). Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed. Oncology New York, 21(8), 976–977.
    Link to Item
- Conference Papers
  - Langer, S., Todd, M., Romano, J. M., Bolger, N., Bricker, J., Syrjala, K. L., … Porter, L. S. (2020). THE RELATIONSHIP INTIMACY MODEL OF COUPLE ADAPTATION TO CANCER: SUPPORT FROM A PROSPECTIVE, LONGITUDINAL, SMARTPHONE-ENABLED ECOLOGICAL MOMENTARY ASSESSMENT STUDY. In Annals of Behavioral Medicine (Vol. 54, pp. S142–S142).
    Link to Item
  - Greenup, R. A., Rushing, C. N., Fish, L. J., Lane, W. O., Peppercorn, J. M., Bellavance, E., … Hwang, E. S. (2019). Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons. In Ann Surg Oncol (Vol. 26, pp. 3141–3151). United States. https://doi.org/10.1245/s10434-019-07594-3
    Full Text Link to Item
  - Chino, F., Suneja, G., Moss, H., Zafar, S. Y., Havrilesky, L., & Chino, J. (2018). Health Care Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status After Medicaid Expansion Under the Affordable Care Act. In Int J Radiat Oncol Biol Phys (Vol. 101, pp. 9–20). United States. https://doi.org/10.1016/j.ijrobp.2017.12.006
    Full Text Link to Item
  - Coronado, D. Y. S., Hahn, T., Albelda, R., Khera, N., Odejide, O. O., Soiffer, R. J., … Abel, G. A. (2017). Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs. In Blood (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.
    Link to Item
  - Sitlinger, A., Sachdev, R., Anderson, D., & Zafar, S. Y. (2017). Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA). In Blood (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.
    Link to Item
  - Chino, F., Peppercorn, J. M., Rushing, C., Samsa, G., Nicolla, J., Altomare, I., & Zafar, S. Y. (2016). "Going for Broke": Out-of-Pocket Costs, Financial Distress, and Patient-Reported Willingness to Pay and Sacrifice in Cancer Care. In International Journal of Radiation Oncology Biology Physics (Vol. 96, pp. S135–S136).
    Link to Item
  - Mowery, Y. M., Salama, J. K., Zafar, S. Y., Moore, H. G., Willett, C. G., Czito, B., … Palta, M. (2016). Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States. In International Journal of Radiation Oncology Biology Physics (Vol. 96, pp. S203–S203).
    Link to Item
  - Zafar, S. Y. (2016). Abstract IA09: Intervening on the financial toxicity of cancer care. In Health Economics, Outcomes, and Policy Research. American Association for Cancer Research. https://doi.org/10.1158/1538-7755.disp15-ia09
    Full Text
  - Irwin, B., Kimmick, G., Altomare, I., Marcom, P. K., Houck, K., Zafar, S. Y., & Peppercorn, J. (2014). Patient experience and attitudes toward addressing the cost of breast cancer care. In Oncologist (Vol. 19, pp. 1135–1140). United States. https://doi.org/10.1634/theoncologist.2014-0117
    Full Text Link to Item
  - Zafar, S. Y., Grothey, A., Bekaii-Saab, T., Bendell, J., Sherrill, B., Bennett, L., … Hurwitz, H. I. (2012). SURVIVAL AMONG METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A RANDOMIZED CONTROLLED TRIAL (RCT) VS AN OBSERVATIONAL COHORT STUDY (OCS). In Annals of Oncology (Vol. 23, pp. 191–191). Vienna, AUSTRIA: OXFORD UNIV PRESS.
    Link to Item
  - Abernethy, A. P., Zafar, S. Y., Coeytaux, R., Rowe, K., Wheeler, J. L., & Lyerly, H. K. (2009). Electronic patient-reported data capture as the foundation of a learning health care system. In Journal of Clinical Oncology (Vol. 27). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
    Link to Item
  - Bullock, K. E., Hurwitz, H. I., Uronis, H. E., Morse, M. A., Blobe, G. C., Hsu, S. D., … Bendell, J. C. (2009). Bevacizumab (B) plus everolimus (E) in refractory metastatic colorectal cancer (mCRC). In Journal of Clinical Oncology (Vol. 27). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
    Link to Item
Teaching & Mentoring
Recent Courses

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Leadership & Clinical Positions at Duke

In the News

Awards & Honors

Subject Headings

Global Scholarship

Research

Selected Grants

External Relationships

Selected Publications

Academic Articles

Conference Papers

Recent Courses